These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 16120770

  • 1. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
    Putral LN, Bywater MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA.
    Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
    [Abstract] [Full Text] [Related]

  • 2. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA.
    Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
    [Abstract] [Full Text] [Related]

  • 4. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Peñalver M, Averette HE.
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [Abstract] [Full Text] [Related]

  • 5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 6. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [Abstract] [Full Text] [Related]

  • 7. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.
    Oncogene; 1999 Apr 08; 18(14):2381-6. PubMed ID: 10327059
    [Abstract] [Full Text] [Related]

  • 8. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S.
    Cancer Res; 2002 Dec 15; 62(24):7364-71. PubMed ID: 12499281
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug 15; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 10. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M.
    Cancer Gene Ther; 2006 Mar 15; 13(3):234-41. PubMed ID: 16138119
    [Abstract] [Full Text] [Related]

  • 11. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S, Hougardy BM, Meersma GJ, Schaap B, de Vries EG, van der Zee AG, de Jong S.
    Mol Pharmacol; 2012 May 15; 81(5):701-9. PubMed ID: 22328720
    [Abstract] [Full Text] [Related]

  • 12. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 15; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 13. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.
    Int J Oncol; 2006 Sep 15; 29(3):541-8. PubMed ID: 16865269
    [Abstract] [Full Text] [Related]

  • 14. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T, Sasaki C, Weinberger P, Psyrri A.
    J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M.
    Gynecol Oncol; 2006 Dec 18; 103(3):820-30. PubMed ID: 16908054
    [Abstract] [Full Text] [Related]

  • 16. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B.
    Cancer Epidemiol Biomarkers Prev; 1996 May 18; 5(5):329-35. PubMed ID: 9162297
    [Abstract] [Full Text] [Related]

  • 17. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC.
    Mol Carcinog; 2011 Jan 18; 50(1):47-57. PubMed ID: 21061268
    [Abstract] [Full Text] [Related]

  • 18. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY, Peng ZL, Wang H.
    Ai Zheng; 2004 Nov 18; 23(11):1257-62. PubMed ID: 15522169
    [Abstract] [Full Text] [Related]

  • 19. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
    Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K, Yoshinouchi M.
    Cancer Gene Ther; 2008 Mar 18; 15(3):140-53. PubMed ID: 18157144
    [Abstract] [Full Text] [Related]

  • 20. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
    Peralta-Zaragoza O, Bermúdez-Morales VH, Madrid-Marina V.
    Rev Invest Clin; 2010 Mar 18; 62(1):63-80. PubMed ID: 20415061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.